Company intelligence / Profile preview

CMCAssist

Ownership: Private
Development stage: Other

Overview

CMCAssist is a specialized CMC consultancy guiding pharmaceutical and biotechnology companies through drug development. They provide expertise in regulatory documentation (IMPDs/INDs), formulation development, manufacturing strategy and optimization, comparability assessments, stability studies, toxicology/clinical formulation work. Their consultants have extensive experience across more than 30 drug development projects with five drugs brought to market[1]. They do not run their own clinical trials or develop proprietary therapeutics but enable client success at all stages up to Phase II[1].

Modalities: PeptidesProteinsMonoclonal antibodyAntibody-drug conjugateSmall moleculeVaccine
Industry: Consulting

Beyond the preview

Go deeper on CMCAssist.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CMCAssist.

Explore the full profile